Interstitial pneumonitis related to rituximab therapy for Waldenström's macroglobulinemia

Rituximab-combined therapeutic regimens have been recommended for treatment of Waldenström's Macroglobulinemia (WM). We report one WM patient who developed interstitial pneumonitis after rituximab therapy.

Detalles Bibliográficos
Autores principales: Bai, Xueyan, Cui, Qu, Liu, Yuanbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352371/
https://www.ncbi.nlm.nih.gov/pubmed/25798285
http://dx.doi.org/10.1002/ccr3.152
_version_ 1782360447280742400
author Bai, Xueyan
Cui, Qu
Liu, Yuanbo
author_facet Bai, Xueyan
Cui, Qu
Liu, Yuanbo
author_sort Bai, Xueyan
collection PubMed
description Rituximab-combined therapeutic regimens have been recommended for treatment of Waldenström's Macroglobulinemia (WM). We report one WM patient who developed interstitial pneumonitis after rituximab therapy.
format Online
Article
Text
id pubmed-4352371
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-43523712015-03-20 Interstitial pneumonitis related to rituximab therapy for Waldenström's macroglobulinemia Bai, Xueyan Cui, Qu Liu, Yuanbo Clin Case Rep Letter to the Editor Rituximab-combined therapeutic regimens have been recommended for treatment of Waldenström's Macroglobulinemia (WM). We report one WM patient who developed interstitial pneumonitis after rituximab therapy. BlackWell Publishing Ltd 2015-02 2014-10-06 /pmc/articles/PMC4352371/ /pubmed/25798285 http://dx.doi.org/10.1002/ccr3.152 Text en © 2014 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Letter to the Editor
Bai, Xueyan
Cui, Qu
Liu, Yuanbo
Interstitial pneumonitis related to rituximab therapy for Waldenström's macroglobulinemia
title Interstitial pneumonitis related to rituximab therapy for Waldenström's macroglobulinemia
title_full Interstitial pneumonitis related to rituximab therapy for Waldenström's macroglobulinemia
title_fullStr Interstitial pneumonitis related to rituximab therapy for Waldenström's macroglobulinemia
title_full_unstemmed Interstitial pneumonitis related to rituximab therapy for Waldenström's macroglobulinemia
title_short Interstitial pneumonitis related to rituximab therapy for Waldenström's macroglobulinemia
title_sort interstitial pneumonitis related to rituximab therapy for waldenström's macroglobulinemia
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352371/
https://www.ncbi.nlm.nih.gov/pubmed/25798285
http://dx.doi.org/10.1002/ccr3.152
work_keys_str_mv AT baixueyan interstitialpneumonitisrelatedtorituximabtherapyforwaldenstromsmacroglobulinemia
AT cuiqu interstitialpneumonitisrelatedtorituximabtherapyforwaldenstromsmacroglobulinemia
AT liuyuanbo interstitialpneumonitisrelatedtorituximabtherapyforwaldenstromsmacroglobulinemia

Ejemplares similares